Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

Abstract Background Although previous studies have evaluated the effect of anti-VEGF therapies for central retinal vein occlusion (CRVO) patients, the majority of previous studies have excluded or included a very small number of patients with ischemic CRVO (iCRVO). The aim of our study is to examine...

Full description

Bibliographic Details
Main Authors: Leangelo Hall, Luma Paiva Frizzera, Laura Fernandes Coelho, Pedro Carlos Carricondo, Maria Kiyoko Oyamada, Sergio Luis Gianotti Pimentel, Maria Fernanda Abalem
Format: Article
Language:English
Published: BMC 2019-07-01
Series:International Journal of Retina and Vitreous
Subjects:
Ischemic central retinal vein occlusion
Bevacizumab
Macular edema
Choroidal thickness
Online Access:http://link.springer.com/article/10.1186/s40942-019-0183-x

Internet

http://link.springer.com/article/10.1186/s40942-019-0183-x

Similar Items